The financial trajectory for the sector indicates a move toward higher-margin, specialized products. According to the current Capsule Market forecast, "Multi-Phase" and "Modified-Release" capsules are poised to dominate new pharmaceutical launches through 2030. These advanced shells allow for the delivery of multiple active ingredients in a single dose—such as a liquid-filled center combined with a time-release powder—enabling complex combination therapies for chronic diseases.

A significant finding in the forecast is the mainstreaming of Enteric-Coated Capsules that bypass the stomach entirely. By releasing active ingredients directly into the small intestine, these capsules reduce gastric irritation and significantly improve the bioavailability of protein-based drugs. The forecast predicts that by 2030, nearly 40% of the market value will be generated by these "Intelligent Delivery" formats, which help pharmaceutical companies extend the patent life of their medications by improving patient adherence and therapeutic outcomes.

Related Reports